AGTR1 and hypertensive disorder: Our study demonstrates that inhibition of the AT1 receptor with AT1 antagonists caused an improvement in the myocardial antioxidant reserve and decreased oxidative stress, and prevented pathophysiological alterations associated with hypertension in rats, which was evident in the protection of histological changes observed in the treatment groups.